These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 5544009)

  • 1. Glibenclamide for diabetes.
    Br Med J; 1971 Feb; 1(5747):473. PubMed ID: 5544009
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with glibenclamide in 300 diabetics.
    Beyer J; Schöffling K
    Postgrad Med J; 1970 Dec; ():Suppl:78-83. PubMed ID: 5500516
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of glibenclamide and chlorpropamide. (Preliminary report).
    Hamblin JJ; Ismay G; Good MS; Wynne-Williams CJ; Baum G; Wilson IV
    Postgrad Med J; 1970 Dec; ():Suppl:92-4. PubMed ID: 5533305
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma insulin and metabolic study on diabetes treated with glibenclamide.
    Anderson J; Coulson R; Grassick BD; Morris BA; Thomas WD; Tomlinson RW; Woodroffe F
    Postgrad Med J; 1970 Dec; ():Suppl:36-41. PubMed ID: 5533294
    [No Abstract]   [Full Text] [Related]  

  • 5. Glibenclamide for secondary failure of other sulphonylureas.
    Stowers JM
    Postgrad Med J; 1970 Dec; ():Suppl;63-5. PubMed ID: 5500519
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of glibenclamide with other oral hypoglycaemic agents.
    Wetherill JH; Tunbridge RE
    Postgrad Med J; 1970 Dec; ():Suppl:88-91. PubMed ID: 5533304
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with glibenclamide in three diabetic clinics.
    Brearley BF; Fawcitt RA; Hirst J
    Postgrad Med J; 1970 Dec; ():Suppl:60-2. PubMed ID: 5533300
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of short-term effects of glibenclamide and chlorpropamide in newly diagnosed diabetics.
    FitzGerald MG; Malino JM
    Postgrad Med J; 1970 Dec; ():Suppl:57-9. PubMed ID: 5533299
    [No Abstract]   [Full Text] [Related]  

  • 9. Glibenclamide in the management of diabetes mellitus. I.
    Devlin JG; Manning K; Harty J
    J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs for type 2 diabetes.
    Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
    [No Abstract]   [Full Text] [Related]  

  • 11. [New glucose regulator. More comfort for the type 2 diabetic patient].
    MMW Fortschr Med; 2001 Feb; 143(6):57. PubMed ID: 11247371
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.
    Vakkilainen J; Mero N; Schweizer A; Foley JE; Taskinen MR
    Diabetes Metab Res Rev; 2002; 18(6):484-90. PubMed ID: 12469362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fasting hyperglycemia and postprandial glucose peaks. Diabetes therapy mustact on 2 sides].
    MMW Fortschr Med; 2003 Aug; 145(33-34):59. PubMed ID: 14526583
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycaemic control in type 2 diabetes.
    Campbell A
    Clin Evid; 2005 Dec; (14):474-90. PubMed ID: 16620416
    [No Abstract]   [Full Text] [Related]  

  • 15. [symbol: see text] Nateglinide and [symbol: see text] repaglinide for type 2 diabetes?
    Drug Ther Bull; 2003 Jul; 41(7):52-4. PubMed ID: 12879789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glibenclamide.
    Drug Ther Bull; 1970 May; 8(10):37-8. PubMed ID: 5420645
    [No Abstract]   [Full Text] [Related]  

  • 17. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
    Campbell IW
    Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, tolerability and safety of nateglinide in combination with metformin. Results from a study under general practice conditions.
    Schatz H; Schoppel K; Lehwalder D; Schandry R
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):262-6. PubMed ID: 12951631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin, glibenclamide plus acarbose in diabetes mellitus?].
    Hauner H
    Dtsch Med Wochenschr; 1995 Nov; 120(46):1605. PubMed ID: 7588044
    [No Abstract]   [Full Text] [Related]  

  • 20. Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.
    Tan MH; Johns D; Strand J; Halse J; Madsbad S; Eriksson JW; Clausen J; Konkoy CS; Herz M;
    Diabet Med; 2004 Aug; 21(8):859-66. PubMed ID: 15270789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.